Pathology of emesis: Its autonomic basis

Handbook of Clinical Neurology

Volumn 117, Issue , 2013, Pages 337-352

  Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; VOMITING;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; HUMANS; VOMITING;

EID: 84884961654     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53491-0.00027-4     Document Type: Chapter

References (136)

1. Abell T.L., Malagelada J.R., Lucas, et al. Gastric electromechanical and neurohumoral function in anorexia nervosa. Gastroenterology 1987, 93:958-965.
2. Abell T.L., Adams K.A., Boles R.G., et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil 2008, 20:269-284.
3. Andrews P.L., Wood K.L. Vagally mediated gastric motor and emetic reflexes evoked by stimulation of the antral mucosa in anaesthetized ferrets. J Physiol 1988, 395:1-16.
4. Andrews P., Torii Y., Saito H., et al. The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur J Pharmacol 1996, 307:305-313.
5. Andrews P.L., Okada F., Woods A.J., et al. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. Br J Pharmacol 2000, 130:1247-1254.
6. Balaban C.D. Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res 1996, 108:367-381.
7. Barnas M.G., Boer W.H., Koomans H.A. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol 1999, 10:2577-2584.
8. Beleslin D.B., Krstic S.K. Dimethylphenylpiperazinium-induced vomiting: nicotinic mediation in area postrema. Brain Res Bull 1986, 16:5-10.
9. Beleslin D.B., Strbac M. Noradrenaline-induced emesis. Alpha-2 adrenoceptor mediation in the area postrema. Neuropharmacology 1987, 26:1157-1165.
10. Beleslin D.B., Strbac M., Jovanovic-Micic D., et al. Area postrema: cholinergic and noradrenergic regulation of emesis. A new concept. Arch Int Physiol Biochim 1989, 97:107-115.
11. Belig A.J., Morrow G.R., Barry M., et al. Autonomic measures associated with chemotherapy-related nausea: techniques and issues. Cancer Invest 1995, 13:313-323.
12. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006, 1. CD005593.
13. Chelimsky T.C., Chelimsky G.G. Autonomic abnormalities in cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2007, 44:326-330.
14. Chen C.Y., Chuang T.Y., Tsai Y.A., et al. Loss of sympathetic coordination appears to delay gastrointestinal transit in patients with spinal cord injury. Dig Dis Sci 2004, 49:738-743.
15. Chhibber A.K., Lustik S.J., Thakur R., et al. Effects of anticholinergics on postoperative vomiting, recovery, and hospital stay in children undergoing tonsillectomy with or without adenoidectomy. Anesthesiology 1999, 90:697-700.
16. Chu K.M., Ngan M.P., Wai M.K., et al. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret. Neuropharmacology 2010, 58:383-391.
17. Cooper D.W., Carpenter M., Mowbra P., et al. Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2002, 97:1582-1590.
18. Costall B., Naylor R.J. Neuropharmacology of emesis in relation to clinical response. Br J Cancer Suppl 1992, 19:S2-S7.
19. Dahmani S., Brasher C., Stany I., et al. Premedication with clonidine is superior to benzodiazepines. A meta analysis of published studies. Acta Anaesthesiol Scand 2010, 54:397-402.
20. Darmani N.A., Crim J.L., Janoyan J.J., et al. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Brain Res 2009, 1248:40-58.
21. Davidson H.I., Andrews P.L. Stimulation of gastrointestinal motility by cisplatin in the ferret: activation of an intrinsic cholinergic mechanism dissociated from emesis. Naunyn Schmiedebergs Arch Pharmacol 1993, 347:506-513.
22. Dornhoffer J., Chelonis J.J., Blake D. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness. Otol Neurotol 2004, 25:740-745.
23. Elinav E., Shapira Y., Ofran Y., et al. Near-fatal amitraz intoxication: the overlooked pesticide. Basic Clin Pharmacol Toxicol 2005, 97:185-187.
24. Farmery A.D., Wilson-MacDonald J. The analgesic effect of epidural clonidine after spinal surgery: a randomized placebo-controlled trial. Anesth Analg 2009, 108:631-634.
25. Fredrikson M., Hursti T.J., Steineck G., et al. Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer 1994, 70:642-645.
26. Fukuda H., Koga T. The Botzinger complex as the pattern generator for retching and vomiting in the dog. Neurosci Res 1991, 12:471-485.
27. Fukuda H., Koga T. Non-respiratory neurons in the Botzinger complex exhibiting appropriate firing patterns to generate the emetic act in dogs. Neurosci Res 1992, 14:180-194.
28. Fukuda H., Koga T. Hypercapnia and hypoxia which develop during retching participate in the transition from retching to expulsion in dogs. Neurosci Res 1993, 17:205-215.
29. 1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs. Brain Res 1998, 802:221-231.
30. 3 receptors and vagal afferents in copper sulfate- and cisplatin-induced emesis in monkeys. Eur J Pharmacol 1993, 249:13-18.
31. 4 receptors in copper sulfate-induced vomiting in dogs. Eur J Pharmacol 1994, 257:47-52.
32. Gan T.J., Shiba A.C., Kovac A.L., et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg 2009, 108:1498-1504.
33. Geling O., Eichler H. Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic reevaluation of clinical evidence and drug cost implications. J Clin Oncol 2005, 23:1289-1294.
34. Gieroba Z.J., Blessing W.W. Fos-containing neurons in medulla and pons after unilateral stimulation of the afferent abdominal vagus in conscious rabbits. Neuroscience 1994, 59:851-858.
35. Golding J.F., Scott J.R. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997, 43:633-637.
36. Goodman S.R., Kim-Lo S.H., Ciliberto C.F., et al. Epinephrine is not a useful addition to intrathecal fentanyl or fentanyl-bupivacaine for labor analgesia. Reg Anesth Pain Med 2002, 27:374-379.
37. Goto J., Inoue K., Mannen T. Autonomic dysfunctions in acute intermittent porphyria. Rinsho Shinkeigaku 1989, 29:774-777.
38. Grant P.J., Hughes J.R., Dean H.G., et al. Vasopressin and catecholamine secretion during apomorphine-induced nausea mediate acute changes in haemostatic function in man. Clin Sci 1986, 71:621-624.
39. Grelot L., Milano S., Portillo F., et al. Membrane potential changes of phrenic motoneurons during fictive vomiting, coughing, and swallowing in the decerebrate cat. J Neurophysiol 1992, 68:2110-2119.
40. Grunberg S.M., Osoba D., Hesketh P.J., et al. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity: an update. Support Care Cancer 2005, 13:80-84.
41. Guy R.J., Dawson J.L., Garrett J.R., et al. Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology. J Neurol 1984, 47:686-691.
42. Hasler W.L. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009, 21:229-243.
43. Hasler W.L., Kim M.S., Chey W.D., et al. Central cholinergic and alpha-adrenergic mediation of gastric slow wave dysrhythmias evoked during motion sickness. Am J Physiol 1995, 268:G539-G547.
44. Hathaway D.K., Abell T., Cardoso S., et al. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 1994, 57:816-822.
45. Hermann G.E., Tovar C.A., Rogers R.C. LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol 2002, 283:G634-G639.
46. α-stimulation of cFos-activation of neurons in the solitary nucleus is suppressed by TNFR:Fc adsorbant construct in the dorsal vagal complex. Brain Res 2003, 976:69-74.
47. Hesketh P.J., Grunberg S.M., Gralla R.J., et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind placebo-controlled trial in patients receiving high-dose cisplatin: the Aprepitant Protocol 052 Study Group. J Clin Oncol 2003, 21:4112-4119.
48. Himi N., Koga T., Nakamura E., et al. Differences in autonomic responses between subjects with and without nausea while watching an irregularly oscillating video. Auton Neurosci 2004, 116:46-53.
49. Ho K.M., Ismail H., Lee K.C., et al. Use of intrathecal neostigmine as an adjunct to other spinal medications in perioperative and peripartum analgesia: a meta-analysis. Anaesth Intensive Care 2005, 33:41-53.
50. Horn C.C. Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus. Auton Neurosci 2009, 148:76-82.
51. Hornby P.J. Central neurocircuitry associated with emesis. Am J Med 2001, 111(Suppl 8A):106S-112S.
52. Huang S.T., Chen G.Y., Lo H.M., et al. Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects. Am J Chin Med 2005, 33:157-164.
53. Ionescu D., Badescu C., Acalovschi I. Nicotine patch for the prevention of postoperative nausea and vomiting: a prospective randomised trial. Clin Drug Investig 2007, 27:559-564.
54. Itoh Y., Oishi T., Ohnishi A., et al. Acute cerebellar ataxia with sympathotonic orthostatic hypotension following Epstein-Barr virus infection: a case report. Rinsho Shinkeigaku 1993, 33:503-506.
55. Janowsky D.S., Risch S.C., Ziegler M., et al. A cholinomimetic model of motion sickness and space adaptation syndrome. Aviat Space Environ Med 1984, 55:692-696.
56. Japundzic-Zigon N., Samardzic R., Beleslin D.B. Clonidine-induced emesis: a multitransmitter pathway concept. Pharmacol Res 1997, 35:287-297.
57. Jordan K., Schmoll H.J., Aapro M.S. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 2007, 61:162-175.
58. Jovanovic-Micic D., Strbac M., Krstic S.K., et al. Ablation of the area postrema and emesis. Metab Brain Dis 1989, 4:55-60.
59. Jovanovic-Micic D., Samardzic R., Beleslin D.B. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis. Eur J Pharmacol 1995, 272:21-30.
60. Kavirajan H., Schneider L.S. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomized controlled trials. Lancet Neurol 2007, 6:782-792.
61. Kim M.S., Chey W.D., Owyang C., et al. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol 1997, 272:G853-G862.
62. Koga T., Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci Res 1992, 14:166-179.
63. Koga T., Fukuda H. Descending pathway from the central pattern generator of vomiting. Neuroreport 1997, 8:2587-2590.
64. Kohl R.L. Autonomic function and plasma catecholamines following stressful sensory stimuli. Aviat Space Environ Med 1993, 64:921-927.
65. Kranke P., Morin A.M., Roewer N., et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002, 95:133-143.
66. Lang I.M., Sarna S.K., Condon R.E. Gastrointestinal motor correlates of vomiting in the dog: quantification and characterization as an independent phenomenon. Gastroenterology 1986, 90:40-47.
67. Lang I.M., Sarna S.K., Dodds W.J. Pharyngeal, esophageal, and proximal gastric responses associated with vomiting. Am J Physiol 1993, 265:G963-G972.
68. Lang I.M., Sarna S.K., Shaker R. Gastrointestinal motor and myoelectric correlates of motion sickness. Am J Physiol 1999, 277:G642-G652.
69. Lee K.Y., Park H.J., Chey W.Y. Studies on mechanism of retching and vomiting in dogs. Effect of peripheral dopamine blocker on myoelectric changes in antrum and upper small intestine. Dig Dis Sci 1985, 30:22-28.
70. Lei Y., Chen J.D. Effects of dual pulse gastric electrical stimulation on gastric tone and compliance in dogs. Dig Liver Dis 2009, 41:277-282.
71. 3 recognition sites on vagal afferent terminals in the brainstem of the ferret. Neuroscience 1990, 38:667-673.
72. Leslie R.A., Shah Y., Thejomayen M., et al. The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting. Can J Physiol Pharmacol 1990, 68:279-288.
73. Lobrano A., Blanchard K., Abell T.L., et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil 2006, 18:162-167.
74. Lurie Y., Wasser S.P., Taha M., et al. Mushroom poisoning from species of genus Inocybe (fiber head mushroom): a case series with exact species identification. Clin Toxicol 2009, 47:562-565.
75. Mack K.J., Johnson J.N., Rowe P.C. Orthostatic intolerance and the headache patient. Semin Pediatr Neurol 2010, 17:109-116.
76. Margalith D., Dunn H.G., Carter J.E., et al. Friedrich's ataxia with dysautonomia and labile hypertension. Can J Neurol Sci 1984, 11:73-77.
77. McCain K.R., Sawyer T.S., Spiller H.A. Evaluation of centrally acting cholinesterase inhibitor exposures in adults. Ann Pharmacother 2007, 41:1632-1637.
78. McCallum R.W., Dusing R.W., Sarosiek I., et al. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol Motil 2010, 22:161-167.
79. Melek I.M., Seyfeli E., Duru M., et al. Autonomic dysfunction and cardiac repolarization abnormalities in patients with migraine attacks. Med Sci Monit 2007, 13:RA47-RA49.
80. Milano S., Grelot L., Bianchi A.L., et al. Discharge patterns of phrenic motoneurons during fictive coughing and vomiting in decerebrate cats. J Appl Physiol 1992, 73:1626-1636.
81. Miller A.D., Nonaka S. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J Pharmacol Exp Ther 1992, 260:509-517.
82. Miller A.D., Ruggiero D.A. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J Neurosci 1994, 14:871-888.
83. 3 receptors. Eur J Pharmacol 2001, 428:215-220.
84. Minami M., Endo T., Hirafuji M., et al. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 2003, 99:149-165.
85. Morrow G.R., Angel C., Dubeshter B. Autonomic changes during cancer chemotherapy induced nausea and vomiting. Br J Cancer Suppl 1992, 19:S42-S45.
86. Morrow G.R., Hickok J.T., Dubeshter B., et al. Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. J Auton Nerv Syst 1999, 78:57-63.
87. Navari R.M. Review of updated antiemetic guidelines for chemotherapy-induced nausea and vomiting. Commun Oncol 2007, 4(1 Suppl.):3S-11S.
88. Navari R.M. Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments. Drugs 2009, 69:515-533.
89. Ngan Kee W.D., Khaw K.S., Ng F.F. Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 2004, 92:469-474.
90. Onishi T., Mori T., Yanagihara M., et al. Similarities of the neuronal circuit for the induction of fictive vomiting between ferrets and dogs. Auton Neurosci 2007, 136:20-30.
91. Palmer G.M., Cameron D.J. Use of intravenous midazolam and clonidine in cyclical vomiting syndrome: a case report. Paediatr Anaesth 2005, 15:68-72.
92. Parkman H.P., Camilleri M., Farrugia G., et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2010, 22:113-133.
93. Patel P.N., Ezzo D.C. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine. Am J Health Syst Pharm 2009, 66:2024-2026.
94. Pedigo N.W., Brizzee K.R. Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis. Brain Res Bull 1985, 14:169-177.
95. Percie du Sert N., Rudd J.A., Moss R., et al. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervations in the ferret. Neurosci Lett 2009, 465:16-20.
96. Percie du Sert N., Chu K.M., Wai M.K., et al. Telemetry in a motion-sickness model implicated the abdominal vagus in motion-induced gastric dysrhythmia. Exp Physiol 2010, 95:768-773.
97. Pyykko I., Schalen L., Jantti V., et al. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness. Acta Otolaryngol 1985, 99:588-596.
98. 3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis. Br J Pharmacol 1993, 108:44-49.
99. Rashed H., Abell T.L., Familoni B.O., et al. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci 1999, 44:74S-78S.
100. Rasmussen K., Morilak D.A., Jacobs B.L. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986, 37:324-334.
101. 3 receptor antagonist granisetron (BRL 43694). Brain Res 1991, 565:231-236.
102. Rosa-e-Silva L., Troncon L.E., Oliviera R.B., et al. Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 1995, 9:179-183.
103. 1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol 1996, 119:931-936.
104. Salin-Pascual R.J., Rosas M., Jimenez-Genchi A., et al. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996, 57:387-389.
105. Schier J.G., Traub S.J., Hoffman R.S., et al. Ephedrine-induced cardiac ischemia: exposure confirmed with a serum level. J Toxicol Clin Toxicol 2003, 41:849-853.
106. Schlegel T.T., Brown T.E., Wood S.J., et al. Orthostatic intolerance and motion sickness after parabolic flight. J App Physiol 2001, 90:67-82.
107. Schulz M., Graefe T., Stuby K., et al. Case report: acute unintentional carbachol intoxication. Crit Care 2006, 10:R84.
108. Sharkey K.A., Cristino L., Oland L.D., et al. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci 2007, 25:2773-2882.
109. Shiroshita Y., Koga T., Fukuda H. Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons. Eur J Pharmacol 1997, 339:183-192.
110. Spinks A.B., Wasiak J., Villanueva E.V., et al. Scopolamine for preventing and treating motion sickness. Cochrane Database Syst Rev 2004, 3. CD002851.
111. Srivastava E.D., Russell M.A., Feyerabend C., et al. Sensitivity and tolerance to nicotine in smokers and nonsmokers. Psychopharmacology (Berl) 1991, 105:63-68.
112. Sullivan S.D., Hanauer J., Rowe P.C., et al. Gastrointestinal symptoms associated with orthostatic intolerance. J Pediatr Gastroenterol Nutr 2005, 40:425-428.
113. Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466-1479.
114. Thal L.J., Ferguson J.M., Mintzer J., et al. A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology 1999, 52:1146-1152.
115. Thrasher D.L., Von Derau K., Burgess J. Health effects from reported exposure to methamphetamine labs: a poison center-based study. J Med Toxicol 2009, 5:200-204.
116. To J., Issenman R.M., Kamath M.V. Evaluation of neurocardiac signals in pediatric patients with cyclic vomiting syndrome through power spectral analysis of heart rate variability. J Pediatr 1999, 135:363-366.
117. Toorop R.J., Scheltinga M.R., Huige M.C., et al. Excessive vomiting abolished by carotid denervation. Auton Neurosci 2007, 133:175-177.
118. Tufanogullari B., White P.F., Peixoto M.P., et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 2008, 106:1741-1748.
119. Uchino M., Ishii K., Kuwahara M., et al. Role of autonomic nervous system for development and suppression of motion sickness in Suncus murinus. Auton Neurosci 2001, 94:46-51.
120. Uchino M., Ishii K., Kuwahara M., et al. Role of the autonomic nervous system in emetic and cardiovascular responses in Suncus murinus. Auton Neurosci 2002, 100:32-40.
121. Uchino M., Ito K., Kuwahara M., et al. Interactions of carotid sinus or aortic input with emetic signals from gastric afferents and vestibular system. Auton Neurosci 2008, 144:36-42.
122. Udassin R., Seror D., Vinograd I., et al. Nissen fundoplication in the treatment of children with familial dysautonomia. Am J Surg 1992, 164:332-336.
123. Urayama Y., Yamada Y., Nakamura E., et al. Electrical and chemical stimulation of the nucleus raphe magnus inhibits induction of retching by afferent vagal fibers. Auton Neurosci 2010, 152:35-40.
124. Van Belle S., Liechinitser M., Navari R.M., et al. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869. Cancer 2002, 94:3032-3041.
125. 1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 2003, 285:G566-G576.
126. Verne G.N., Soldevia-Pico C., Robinson M.E., et al. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol 2004, 38:72-76.
127. Villafane G., Cesaro P., Rialland A., et al. Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. Eur J Neurol 2007, 14:1313-1316.
128. Vinograd I., Udassin R., Beilin B., et al. The surgical management of children with familial dysautonomia. J Pediatr Surg 1985, 20:632-636.
129. West P., Horowitz B.Z. Zigadenus poisoning treated with atropine and dopamine. J Med Toxicol 2009, 5:214-217.
130. Wilkinson A.R., Frampton C.M., Glover P.W., et al. Preoperative transdermal hyoscine for the prevention of postoperative nausea and vomiting. Anaesth Intensive Care 1989, 17:285-289.
131. Wood C.D., Stewart J.J., Wood M.J., et al. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviat Space Environ Med 1990, 61:157-161.
132. Yamada Y., Tsukamoto G., Kobashi M., et al. Abdominal vagi mediate c-Fos expression induced by X-ray irradiation in the nucleus tractus solitarii of the rat. Auton Neurosci 2000, 83:29-36.
133. Yasumura S., Shojaku H., Watanabe Y. Prediction of vestibule-autonomic symptoms during the caloric test: evaluation of autonomic activity by spectral analysis of the electrocardiographic R-R interval. Acta Otolaryngol 2005, 125:1265-1271.
134. Yates B.J., Miller A.D., Lucot J.B. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998, 47:395-406.
135. Zachariae R., Paulsen K., Mehlsen M., et al. Chemotherapy-induced nausea, vomiting, fatigue: the role of individual differences related to sensory perception and autonomic reactivity. Psychother Psychosom 2007, 76:376-384.
136. Zingler V.C., Denecke K., Jahn K., et al. The effect of nicotine on perceptual, ocular motor, postural, and vegetative functions at rest and in motion. J Neurol 2007, 254:1689-1697.